Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Hookipa Pharma Inc on Thursday said it is not going ahead with a bid for Poolbeg Pharma PLC.
In a brief statement regarding a possible combination between the two firms, the US-listed biopharmaceutical company said ‘it does not intend to make an offer for Poolbeg.’
‘Non-binding’ and ‘non-exclusive’ talks between the two firms were announced in early January.
Under the proposed terms announced in January, shareholders in Poolbeg, the London-based clinical stage biopharmaceutical firm, would have received 0.03 Hookipa shares for each Poolbeg share.
Shares in Poolbeg closed down 2.9% at 4.71 pence each in London on Thursday.
Copyright 2025 Alliance News Ltd. All Rights Reserved.